• Comment
• Tweet

Risk of Death From Certain Breast Cancers May Rise With Age

Research focused on estrogen-sensitive tumors; undertreatment might play a role, expert says

Funding for the current study was provided by the Dutch Cancer Society. The initial trial received an education grant from Pfizer, the company that manufactures Aromasin.

More information

Learn more about available breast cancer treatments from the American Cancer Society.

Copyright © 2012 HealthDay. All rights reserved.

• <
• 1
• 2

Tags:

senior health,

women's health,

cancer,

chemotherapy,

therapy,

breast cancer,

hormones

Reader Comments

Add Your Thoughts

Comment Name State Select One AL AK AZ AR CA CO CT DE DC FL GA HI ID IL IN IA KS KY LA ME MD MA MI MN MS MO MT NE NV NH NJ NM NY NC ND OH OK OR PA RI SC SD TN TX UT VT VA WA WV WI WY International Email

Please enter the two words below into the text field underneath the image.

Incorrect please try again

Enter the words above: Enter the numbers you hear:

Your comment will be posted immediately, unless it is spam or contains profanity. For more information, please see our Comments FAQ.